Should AI assist in surgical decision-making?

May 18, 2020 Artificial Intelligence, Digital Surgery, Innovation, Medical Devices, Robotics

There’s a push for AI/ML to reduce the staggering number of preventable deaths due to surgical error.

The first and second leading causes of death in the United States are heart disease and cancer. The third is now coronavirus. Know what’s next?

Astoundingly, the answer is preventable medical errors. Surgical errors in particular account for 26% of these deaths and cost somewhere north of $36 billion in the U.S. I did a double take when I read those stats while reporting this story. Some of the most common laparoscopic procedures, things like colectomies, hysterectomies, and gastrectomies result in an astounding number of preventable deaths.

Fully automated surgeries performed by robots is still a ways off. In the meantime, developers are trying to beat those grim numbers by harnessing the best of human decision making and coupling it with truly exceptional technology tools designed to assist surgeons. Artificial intelligence and machine learning are often touted as solutions for call centers and to provide intelligent insights to companies that have reams of data that needs to be processed, but leveraging AI/ML to better medical outcomes could be one of the transformative technologies of our time.

“Surgical decision-making is dominated by hypothetical-deductive reasoning, individual judgment, and heuristics,” write the authors of a recent JAMA Surgery paper called Artificial Intelligence and Surgical Decision-making. “These factors can lead to bias, error, and preventable harm. Traditional predictive analytics and clinical decision-support systems are intended to augment surgical decision-making, but their clinical utility is compromised by time-consuming manual data management and suboptimal accuracy.”

The paper’s authors propose AI as an effective augmentation tool to enhance in situ surgical decision making. We’re already seeing the first examples of this come to market. For example, a company called Activ Surgical, a digital surgery company focused on improving patient outcomes, recently debuted its ActivEdge platform, an AI/ML platform designed to provide critical real-time intelligence and visualization to surgeons. The platform and its associated products will be initially available in the U.S. market, with plans to commercialize globally in 2021.

“The future of surgery is collaborative, with human judgment and wisdom augmented by robotics precision,” said Todd Usen, CEO, Activ Surgical. “With nearly 400,000 deaths in the U.S. every year due to avoidable medical errors, our surgical intelligence platform is designed to dramatically improve outcomes, safety and accessibility by arming surgeons with real-time information to make better informed decisions. We look forward to empowering global access to best-in-class surgery, regardless of location, saving millions of lives in the process.”

By Greg Nichols | ZDNet

Image Credit: Greg Nichols / ZDNet

READ MORE

About Peter Coffaro 510 Articles

Peter Coffaro is a growth-driven and strategic executive with over 25 years of progressive management success in the medical device industry. With a proven track record and recognized expertise, Peter has established himself as one of the top influencers in medical sales, as acknowledged by prestigious publications such as the World Journal of Orthopedics, Exponential Healthtech, and MedReps.com. Throughout his career, Peter has accumulated 10 years of combined sales management experience, excelling in various roles including Director, General Manager, Distributor, and Vice President. He has worked for industry-leading orthopedic companies such as Zimmer, DePuy, and Stryker, solidifying his deep knowledge and network within the field. Peter’s passion for innovation and emerging technologies led him to found OrthoFeed, an award-winning blog covering digital orthopedic news and emerging medical technologies. Through this platform, he stays at the forefront of the industry and contributes to the dissemination of valuable insights. Peter is a three-time Hall of Fame award winner at Johnson and Johnson, demonstrating his exceptional contributions and impact on the organization. His expertise extends to areas such as organizational development, business development, sales management, digital marketing, and professional education. Peter earned a B.S. degree in Biology and Chemistry from Northern Illinois University, further complementing his comprehensive understanding of the medical field. With his wealth of experience, strategic mindset, and dedication to advancing healthcare, Peter Coffaro is a valuable asset and leader in the medical device industry.